Plus   Neg

Continental AG Withdraws Guidance - Quick Facts

Continental AG (CTTAY.PK) said, due to business impacts from COVID-19 Pandemic, the company's Executive Board has decided to withdraw the outlook for fiscal 2020. Over 40 percent of Continental's production locations worldwide have temporarily ceased activities.

For the first quarter of fiscal 2020, based on the most recent preliminary key data, Continental AG expects consolidated sales of around 9.4 billion euros to 9.8 billion euros, and an adjusted EBIT margin of around 2% to 3%. In the Automotive divisions, sales are expected to be around 5.7 billion euros to 5.9 billion euros.

Continental AG said the company is implementing numerous measures to adapt costs and reduce demands on liquidity. This includes actions to adjust working times as well as wage and salary costs.

As at February 29, 2020, the company had cash and cash equivalents of around 2.3 billion euros and committed unused credit lines of around 4.6 billion euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic. AstraZeneca Plc and Oxford University's coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately prepare regulatory submission of the data to worldwide authorities for conditional or early approval. The company will also ask for an Emergency Use Listing from the WHO.
Follow RTT